Skip to main content
SSY Group Limited logo

SSY Group Limited — Investor Relations & Filings

Ticker · 2005 ISIN · KYG8406X1034 HKEX Manufacturing
Open in API
Filings indexed 1,212 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country HK Hong Kong
Listing HKEX 2005

About SSY Group Limited

http://www.ssygroup.com.hk

SSY Group Limited is an investment holding company specializing in the research, development, manufacturing, and sale of pharmaceutical products. The Group is a prominent manufacturer, with a core focus on producing a wide range of intravenous infusion solutions and finished drugs. Complementing its pharmaceutical offerings, the company also manufactures essential packaging materials, including non-PVC soft bags and PP plastic containers. SSY Group supplies its comprehensive product line, which often utilizes green production technologies aimed at reducing costs and power consumption, primarily to hospitals and medical institutions.

Recent filings

Filing Released Lang Actions
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 76% confidence The document is a voluntary business update announcement on product development (approval of Safinamide Mesylate) by the board. It is not an AGM notice, financial report, earnings release, capital change, management changes, or any specialized form. It represents a general regulatory announcement without fitting into other specific categories, so it falls under the fallback category “Regulatory Filings” (RNS).
2026-05-26 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 85% confidence The document is a voluntary business update announcement regarding product development (approval of Azilsartan Medoxomil Potassium) filed on HKEX. It contains no financial results, no meeting notices, no dividends, no share transactions, and no substantive report attached. It is a general regulatory announcement and does not fit any specific category, so it defaults to Regulatory Filings (RNS).
2026-05-21 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON PRODUCT DEVELOPMENT
Regulatory Filings Classification · 85% confidence The document is a voluntary business update announcement by SSY Group Limited regarding product development approvals from China’s NMPA. It does not contain financial statements, governance rules, shareholder votes, management changes, financing details, or dividend information. It is a general regulatory announcement filed with the Hong Kong Stock Exchange, falling into the fallback category.
2026-05-21 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 90% confidence The document is a ‘Next Day Disclosure Return’ (Form FF305) filed under Hong Kong Stock Exchange listing rules, detailing changes in issued shares, treasury share repurchase and on-market sales. It is not announcing publication of a separate report but is itself the disclosure of share transactions by the issuer. This aligns with the “Transaction in Own Shares” category (POS) for share repurchases/treasury share sales.
2026-05-21 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 98% confidence The document is a ‘Next Day Disclosure Return’ required under Hong Kong Listing Rules, detailing the issuer’s repurchase of 2,000,000 shares (held as treasury shares), changes in issued and treasury share balances, repurchase prices, mandate details, and confirmations by the company secretary. This is not a general report publication announcement or an interim/annual report but a specific notice of the company’s transactions in its own shares. Therefore, it should be classified under Transaction in Own Shares (POS).
2026-05-20 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 100% confidence The document is titled 'Next Day Disclosure Return' and relates to changes in issued shares or treasury shares, including share buybacks and on-market sales of treasury shares. It references specific listing rules from the Hong Kong Stock Exchange (Main Board Rules and GEM Rules) and provides detailed data on share repurchases, including dates, prices, and quantities. The document includes confirmations about compliance with listing rules and legal requirements. It is a regulatory disclosure about share repurchase activity rather than a financial report or earnings release. This fits the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares.
2026-05-19 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.